Comparison between the Effect of Fenofibrate and Clofibrate on Term Neonates with Hyperbilirubinemia
Phase 3
- Conditions
- eonatal jaundice.Neonatal jaundice from other and unspecified causes
- Registration Number
- IRCT20190708044158N1
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Term neonates(37 weeks to 41 weeks and 6 days) that their ages are more than 72 hours.
They were admitted for jaundice, total bilirubin serum more than 15 mg/dl.
They were otherwise healthy.
They did not receive therapy other than phototherapy.
Exclusion Criteria
Premature neonates
IUGR infants
Neonates with congenital anomaly
Neonates with blood group and RH incompatibility
Neonates with G6PD deficiency
Neonates with history of maternal phenobarbital consumption
Neonates with respiratory distress and signs and symptoms of sepsis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum bilirubin level. Timepoint: Admission time, second day, third day, discharge time. Method of measurement: Spectrophotometric method with the biochemical kit ( made in Iran ).
- Secondary Outcome Measures
Name Time Method Duration of need to phototherapy and hospital stay. Timepoint: From the time of admission until discharge. Method of measurement: Duration of time by hour.